Ci Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration (FDA). On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor.
Source: Wikipedia
Kër bu mag251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Sos nañu ko2018
NekkinDox
Brevet1 brevet
GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR TREATMENT AND PREVENTION OF CNS DISORDERSEP2326310B1 · 2019
Xool
Amul xool. Liggéey nga ak Assertio Therapeutics, Inc.? Doon ki njëkk a séddoo sa xam-xam.
Xibaaru yoon
| Turu yoon | Assertio Therapeutics, Inc. |
|---|---|
| LEI | 549300L2A9NTF1JVDP20Xool ci GLEIF ↗ |
| Adresu bindu | 251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US |
| Nekkin | Dox |
Cosaan: GLEIF · yeesal Oct. 16, 2026
Jokkoo & lëkkalekaay
Barab
251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Ndax sa sosiete la?
Jël xët bii bu amul fay ngir yokk sa logo, yëf, nataal ak liggéey, te tontu xool.
Jël xët biiBokku ci Heelky ngir jokkoo, jëfandikoo ak yokkte
Sos kont bu amul fay ngir yónnee nit, jot liggéey te yónnee misiyooŋ.
Bokku léegi — amul fay